Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: Vodafone Group Plc (ADR)(NASDAQ:VOD), EMC Corporation(NYSE:EMC), PowerShares QQQ Trust, Series 1 (ETF)(NASDAQ:QQQ), CytRx Corporation(NASDAQ:CYTR)
Vodafone Group Plc (ADR)(NASDAQ:VOD) traded at the price of $38.81 recently on a traded volume of 2.80 million shares, in comparison to 7.18 million shares of average trading volume. So far this year, the stock is down over -1.17%. The company has a total market capitalization of $188.08 billion and its total outstanding shares are 4.85 billion. Vodafone Group Plc (Vodafone) is a mobile communications company. The Company provides its services to mobile voice, messaging, data and fixed line. Vodafone has equity interests in telecommunications operations in nearly 30 countries and around 50 partner networks worldwide.
Can Investors Bet on VOD after this News update? Find out in this Research Report
EMC Corporation(NYSE:EMC) plunged -0.16% at the trading price of $25.51 on a traded volume of 11.49 million shares till now, whereas its average trading volume is 22.29 million shares. In the last three months, the stock is up 3.91%. The Intra-day range for the stock is $25.43 and $25.82. EMC Corporation (EMC), and its subsidiaries develop, deliver and support the Information Technology (IT) industry’s range of information infrastructure and virtual infrastructure technologies, solutions and services.
Has EMC Found The Bottom And Ready To Gain Momentum? Find Out Here
PowerShares QQQ Trust, Series 1 (ETF)(NASDAQ:QQQ) jumped up 0.31% at the $87.39recently. So far in three months, the stock is up 13.2%. The 52-week range for the stock is $86.94and $87.55. Its introductory price for the day was $87.11, with the overall traded volume of 11.67 million shares. PowerShares QQQ Trust, Series 1 (the Trust) is a unit investment trust that issues securities called PowerShares QQQ Index Tracking Stock. The Trust holds all of the component securities of the Nasdaq-100 Index (the Index). The Investment objective of the Trust is to provide investment results that generally correspond to the price and yield performance of the Nasdaq-100 Index.
Will QQQ Continue To Move Higher? Find Out Here
CytRx Corporation(NASDAQ:CYTR), after opening its shares at the price of $7.29, jumped up8.07% , its recent trading price was $6.95 for the day. The stock moved on a traded volume of 5.86 million shares, in comparison to 5.37 million shares of average trading volume.
The 52-week range for the stock is $1.83and $7.50. Its introductory price for the day was $7.29. CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology. The Company's oncology pipeline includes three programs in clinical development for cancer indications: INNO-206, tamibarotene and bafetinib. INNO-206 is the Company's tumor-targeted doxorubicin conjugate. On May 13, 2011, the Company sold all pre-clinical and clinical data, intellectual property rights and other assets relating to those compounds to Orphazyme ApS.
Why Should Investors Buy CYTR After The Recent Gain? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)